300143 盈康生命
2025/12 -
人民幣(K¥)

变动
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入1,885,56720.93%1,470,7981,156,2461,089,8671,028,882
减:营业总成本1,676,57517.78%1,319,4531,045,5211,031,050934,794
    其中:营业成本1,374,63918.92%1,054,905849,464828,999746,237
               财务费用11,0841,060.64%1,6612,26212,97316,563
               资产减值损失(3,246)-20.16%(4,115)(668,751)(451,147)(24,708)
公允价值变动收益(46,000)741.03%(3,136)------
投资收益13,9131,514.51%1,2664,07371,5563,220
    其中:对联营企业和合营企业的投资收益------------
营业利润163,60527.82%142,010(554,896)(325,261)69,756
利润总额151,6441.59%131,522(565,186)(324,583)201,032
减:所得税费用64,29493.19%32,32330,65031,75251,295
净利润87,350-24.69%99,199(595,836)(356,335)149,738
减:非控股权益18,8103,246.68%(1,238)827,7461,213
股东净利润68,541-40.62%100,436(595,918)(364,080)148,525

市场价值指针
每股收益 (元) *0.090-50.00%0.160-1.010-0.5700.250
每股派息 (元) *0.025----------
每股净资产 (元) *3.3523.36%2.1521.9982.7623.442
审计意见 #标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见--
回页顶
备注: *未调整数据
#只提供简体内容